Itch refers to an aversive sensation that generates a desire to scratch. The basolateral amygdala (BLA) activity is crucial in driving motivation, sensation, and emotional responses. Excitatory projections from the BLA play a vital role in turning neuronal activity throughout the brain, including the medial prefrontal cortex (mPFC). Nevertheless, whether the BLA neurons and BLA-mPFC circuit contribute to itch sensation remains elusive. In this study, fluoro-gold retrograde tracing, morphological staining and neuronal manipulation approaches were employed to investigate the role of BLA-mPFC projections in itch processing. Results showed that glutamatergic neurons in the BLA were activated in response to histamine- and chloroquine-induced acute itch stimuli. Chemogenetic activation of these neurons significantly mitigated the scratching behavior, while their inhibition increased the number of scratching bouts. The percentages of fluoro-gold-labeled CaMKII neurons expressing FOS in the BLA, which projecting to the mPFC, were 40.10±2.26% and 73.84±6.48% in acute itch models induced by histamine and chloroquine, respectively. Optogenetic activation of the BLA-mPFC pathway reduced histamine or chloroquine-induced scratching bouts, whereas its inhibition increased the scratching bouts. These results provide evidence that BLA-mPFC projections are implicated in the acute itch processing, expanding our understanding to the circuit mechanism underlying the modulation of itch.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jid.2025.02.138 | DOI Listing |
Pain
March 2025
Neurophysiology Laboratory, Department of Biomedicine, Medical School, Institute of Neurosciences, Universitat de Barcelona, Barcelona, Spain.
A subset of peripheral sensory neurons expressing specific Mas-related G-protein-coupled receptors and transient receptor potential channels mediate pruritogen-induced chemical itch. However, the molecular mechanisms that regulate the excitability of these cells, and consequently itch sensation, are poorly understood. TWIK-related spinal cord K + channel (TRESK) is a background K + channel that modulates the resting membrane potential, action potential firing, and neuronal excitability, and it has been involved in somatosensation and pain transduction.
View Article and Find Full Text PDFJ Asthma Allergy
March 2025
Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Background: Atopic dermatitis (AD) is a common inflammatory disease with heterogeneous clinical features. Certain meaningful phenotypes and clinical features may help better classify AD patients for personalized medicine. To our knowledge, no ideal predictors have been found so far.
View Article and Find Full Text PDFAllergic contact dermatitis (ACD) is an inflammatory dermatitis with a high morbidity and recurrence rate. Scientific attention is focused on the development of safe and comfortable therapeutics of ACD. Herein, we propose a natural matrine-integrated pollen delivery system for the ACD treatment.
View Article and Find Full Text PDFJ Invest Dermatol
March 2025
Department of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, China. Electronic address:
Itch refers to an aversive sensation that generates a desire to scratch. The basolateral amygdala (BLA) activity is crucial in driving motivation, sensation, and emotional responses. Excitatory projections from the BLA play a vital role in turning neuronal activity throughout the brain, including the medial prefrontal cortex (mPFC).
View Article and Find Full Text PDFWorld J Hepatol
February 2025
Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent 9000, Belgium.
Background: Benign recurrent intrahepatic cholestasis (BRIC) is a rare autosomal recessive liver disease, causing episodic cholestasis with intense pruritus. This case report highlights the effectiveness of early plasmapheresis as a therapeutic option for BRIC type 2, offering rapid symptom relief and early termination of cholestatic episodes. It contributes to the limited evidence supporting plasmapheresis as a treatment for BRIC flares resistant to conventional therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!